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SIJMMARY. Experimental evidence has indicated that T lymphoblasts are more 
sensitive to deoxynucleoside toxicity than are B lymphoblasts. These data have 
led to the use of purine enzyme inhibitors as selective chemotherapeutic drugs 
in the treatment of T cell malignancies ranging from T cell acute lymphoblastic 
leukaemia to cutaneous T cell lymphomas. We have compared the toxicities of 
2’-deoxyadenosine, 2’-deoxyguanosine, and thymidine for T cell lines derived 
from patients with T cell acute lymphoblastic leukaemia with those for mature T 
cell lines derived from patients with cutaneous T cell leukaemia/lymphoma. We 
have found that both deoxynucleosides are far less toxic to the mature T cell lies 
than to T lymphoblasts and that the mature cells accumulate much lower 
amounts of dATP and dGTP when exposed to deoxyadenosine and deoxyguano- 
sine, respectively. Similar studies performed on peripheral blood cells from 
patients with T cell leukaemias of mature phenotype and on peripheral blood T 
cells demonstrate similar low amounts of deoxynucleotide accumulation. 
Measurements of the activities of several purine metabolizing enzymes that 
participate in deoxynucleoside phosphorylation or degradation do not reveal 
differences which would explain the toxicity of deoxynucleosides for immature, 
as compared to mature, T cells. We conclude that deoxynucleoside metabolism 
in leukaemic T cells varies with their degree of differentiation. These observa- 
tions may be relevant to the design of chemotherapeutic regimes for T cell 
malignancies. 
Two inborn errors of purine metabolism have been associated with severe numerical deficits 
of mature T lymphocytes. Adenosine deaminase (ADA) deficiency results in severe combined 
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immunodeficiency disease, generally with a more profound loss of T than of B cells (Giblett et 
al, 19 7 2 ) ,  whereas purine nucleoside phosphorylase (PNP) deficiency results in an isolated T 
cell deficit (Giblett et al, 1975). The loss of T lymphocytes in these disorders was initially 
attributed exclusively to the selective metabolism of the deoxynucleoside substrates of these 
enzymes (2’-deoxyadenosine (AdR) in the case of ADA deficiency and 2’-deoxyguanosine 
(GdR) in the case of PNP deficiency) to the corresponding deoxynucleoside triphosphate 
(dATP or dGTP) in T cells (Coleman et al, 1978; Mitchell et al, 1978; Carson et al, 1978). The 
T cells employed in the in vitro studies leading to this hypothesis were cultured lymphoblasts 
initially derived from patients with T cell acute lymphoblastic leukaemia. 
Clinical studies with the ADA inhibitor, 2’-deoxycoformycin, have indeed confirmed that 
dATP readily accumulates in the lymphoblasts from patients with T cell acute lymphoblastic 
leukaemia when ADA is inhibited in vivo and that dATP accumulation is associated with 
cytotoxicity (Prentice et al, 1981; Mitchell et ul, 1980; Grever et al, 1981). In addition, 
however, 2‘-deoxycoformycin induces profound lymphopenia in patients with solid tumours 
(Smyth, 1979), as well as in patients with cutaneous T cell lymphomas (Siaw et al, 1980; 
Grever et al, 19 83) and chronic lymphocytic leukaemia of T cell origin (Hallam et al, 1984). In 
contrast to the studies on T lymphoblasts, the mechanism(s) underlying the lysis of mature 
normal and malignant T cells has (have) not yet been definitively established. We have 
therefore compared the cytotoxic effects and metabolism of AdR, GdR and thymidine (TdR) in 
leukaemic lymphoid cells and cell lines of mature phenotype with those in immature T 
lymphoblasts. 
MATERIALS AND METHODS 
Reagents. 2’-Deoxycoformycin was a gift of the Warner-Lambert Co., Ann Arbor, Mich. 
The PNP inhibitor, 8-aminoguanosine, was obtained from Dr Leroy Townsend, Department 
of Medicinal Chemistry, University of Michigan, Ann Arbor, Mich. (Kazmers et ul, 1981). 
Cell lines and growth experirnents. Human T and B lymphoblast lines were obtained, as 
described previously (Mitchell et al. 1978). The mature T cell lines HUT 78 and HUT 102 have 
also been described previously (Poiesz et al, 1980; Gazdar et al ,  1980). HIJT 102 cells were 
obtained from the lymph node of a patient with adult T cell leukaemia lymphoma and the 
human T cell leukaemia virus (HTLV) was originally isolated from this cell line. HUT 78 was 
established from the peripheral blood cells of a patient with the Sezary syndrome and is not 
infected with HTLV. Both lines have surface antigens reactive with OKTl and T4 monoclonal 
antibodies and lack OKT8 antigens. 
Exponentially growing cells were suspended at a concentration of 2 x lo5 cells/ml in 
RPMI-1640 medium, 10% horse serum, and the additives indicated in a final volume of 100 
pl in flat-bottom microtitre plates (Corning, N.Y.). Each experiment was performed in 
triplicate and control growth was exponential over 96 h. 
Leukaemic cell isolation and incubations. Mononuclear cells were obtained from the 
heparinized peripheral blood of normal controls or patients with T cell leukaemia and 
separated on Ficoll-Hypaque gradients. Of the four patients studied, one (O.B.) had a T cell 
leukaemia/lymphoma characterized by severe hypercalcaemia and rapidly progressive 
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cutaneous lesions (Bunn et al, 1983). In the leukaemic phase her peripheral blood T cells 
reacted with the monoclonal anti-Tac antibody and were thus positive for the T-cell growth 
factor receptor (Leonard et al, 1983). In addition, her serum was positive for antibodies to the 
major core protein (p24) of HTLV I. She was thus diagnosed as having retrovirus-associated 
adult T-cell leukaemia/lyphoma. Cells from the other three patients were unreactive with the 
anti-Tac antibody and all sera were negative for antibodies to HTLV. E.M. was felt to have T 
cell chronic lymphocytic leukaemia, L.M. a cutaneous T cell lymphoma in the leukaemic 
phase, and L.K. an unusual and highly malignant T cell leukaemia of mature phenotype 
(Schnitzer et al, 1982). Normal peripheral blood T cells were isolated by conventional sheep 
erythrocyte rosetting techniques. 
Cells were incubated at a final concentration of 2 x lo5 cells/ml in RPMI-1640 medium 
with 10% horse serum and the additives indicated. 2’-Deoxycoformycin and 8-aminoguano- 
sine were added 30 min prior to the addition of AdR or GdR to allow maximal inhibition of 
ADA or PNP activity. Following the incubations, cells were sedimented at 400 g and 
extracted in 1 ml 60% methanol at - 20°C for 24 h. Ribo- and deoxyribonucleotides were 
separated by high pressure liquid chromatography on a Partisil-10 SAX anion-exchange 
column (Whatman, Clifton, N.J.), using an ammonium phosphate elution gradient 
(0.3-0.45 M, pH 3.3-3.6) over 35 min at a flow rate of 2 ml/min. When insufficient cells 
were available for HPLC analysis, levels of deoxyribonucleoside triphosphates were measured 
using a modification of the DNA polymerase assay, as previously described (Mitchell et al, 
1978). 
Measurements of enzyme uctivities. Cellular cytoplasmic extracts were prepared from 
approximately 2 x 1 O8 lymphoid cells during exponential growth. The cells were washed 
twice in Hanks balanced salt solution and resuspended in 1.5 ml10 mM Hepes buffer pH 7.4, 
0.5 mM MgClz, and 0.1 5 M NaCl. An equal volume of 0.5 M sucrose was slowly added to the 
cold cell suspension and the cells were lysed by nitrogen cavitation bomb at 4OC, as previously 
described (Mitchell & Edwards, 1984). Assays for ecto-5-nucleotidase activity, ADA and PNP 
activities were performed as previously described (Wortman et al, 1979), as were the assays 
for adenosine kinase, deoxycytidine kinase, and deoxyadenosine phosphorylating activity 
(Hurley & Fox, 1983). Final substrate concentrations were 1 7  p~ for adenosine, 20 C(M for 
GdR, and 500 DM for AdR. 
RESULTS 
Effects of the deoxynucleosides on cell growth and metabolism 
The effects of deoxynucleosides, AdR, GdR and TdR, on the growth of cultured cutaneous T 
cell leukaemia cell (CTCL) lines are compared to their effects on the growth of human T and B 
lymphoblasts in Table I. Previous studies have demonstrated marked enhancement of AdR 
toxicity for T lymphoblasts by the ADA inhibitor 2’-deoxycoformycin (Sylwesterowicz et al, 
1982) and of GdR toxicity by the PNP inhibitor, 8-aminoguanosine (Kazmers et al, 1981). 
Neither inhibitor alone has any effect on cell growth. Hence, comparison of AdR and GdR 
toxicities are made in the presence of 2’-deoxycoformycin or 8-aminoguanosine, respect- 
ively. It is apparent that the IDsos of AdR and GdR for the CTCL lines are comparable to those 
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Table I. Comparative effects of 2’-deoxyadenosine, 2’4eoxyguanosine and thymidine on the 
growth of cutaneous T cell leukemia cell lines, T lymphoblasts, and €3 lymphoblasts 
CTCL T lymphoblasts B lymphoblasts 
HUT 102 HUT 78 MOLT 4 KPMI 8402 MGL 8 GM 558 
Doubling time (h) 54 54 19 31 36 30 
IDSO* 
AdK (PM)+ 10 PM dCF 39 3 3  0.9 0.8 58 64 
GdR ( p ~ ) +  100 PM 8-AGuo 22 2 0  1.3  0.9  1 8  1 7  
TdR (PM) 3 50 520 75 18 9 8 0  480 
* The ID50 is the concentration ofdeoxyribonucleoside causing 50% inhibition of growth after 
72 h as compared to control cells grown in the presence of 10 PM 2’-deoxycoformycin. 1 00 PM 
8-aminoguanosine, or no additives for AdK, GdK and TdK. respectively. Values represent a 
mean of three experiments performed in triplicate. 
for B lymphoblasts and 20- to 30-fold higher than those for T lymphoblasts. In addition, TdK 
is far less inhibitory to the growth of CTCL cells and B lymphoblasts than it is to the growth of 
T lymphoblasts. 
In order to see whether the relative resistance of the mature CTCI, lines to deoxynucleo- 
sides was reflected in their synthesis and/or accumulation of the corresponding deoxynucleo- 
side triphosphates, CTCL cells, T lymphoblasts and B lymphoblasts were incubated for 4 and 
2 4  h with (a) 50 PM 2’-deoxyadenosine+10 PM 2’-deoxycoformycin, and (b) 50 PM 
2‘-deoxyguanosine + 100 PM 8-aminoguanosine. Cells were extracted and nucleotide pool 
sizes were determined by HPLC. As summarized in Table II, CTCL cells accumulated far less 
dATP and dGTP from the corresponding deoxynucleosides at both time points than did the T 
lymphoblasts, but did not differ significantly from the I3 lymphoblasts. 
Since the CTCL cell lines clearly have been selected for their ability to proliferate 
indefinitely in tissue culture and since active cell cycling may affect the size of deoxynucleo- 
tide pools, leukaemic cells were isolated from the peripheral blood of four patients with T cell 
leukaemias of mature phenotype (T4+ and/or T8+).  The T8+ cells from L.M. accumulated 
several-fold the baseline level of dATP and dGTP, but cells from the three other patients and 
normal T lymphocytes failed to accumulate dATP and dGTP under the same conditions. 
Since ATP depletion has been invoked as a possible mechanism of mature lymphocyte 
depletion resulting from deoxycoformycin treatment (Siaw ut al, 1980; Carson et al, 1982). 
ATP levels were monitored by HPLC in cultured cells incubated with AdR and 2‘-deoxycofor- 
mycin and the results are shown in Table 111. CTCL cells showed a modest rise in ATP levels at 
4 h and a slight decline of AT!? levels at 24 h when compared to cells cultured in the presence 
of 2’-deoxycoformycin alone. The RPMI-8402 T lymphoblast line demonstrated a consistent 
decline in ATP values during the incubations which was not seen in the Molt-4 T 
lymphoblasts. In contrast to both these observations, B lymphoblasts had a pronounced early 
decline in ATP levels at 4 h with a recovery to levels higher than the control values at 24 h. 
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(pmoI/ 1 O6 cells) 
Surface 
Cell type markers Control 4 h 24 h Control 4 h 24 h 
CTCL 
HUT 78 T4 + 2 1 f 2  6Yf l  5 2 f 2  13&6 2 6 f l l  3 1 f 4  
HUT 102 T4+ 1 4 f 6  3 4 f 3  4 4 f 3  1 9 f 5  4 8 f 2 4  3 9 f 1 0  
T lymphoblasts 
MOLT 4 T l l '  1 8 f 5  5 7 3 f 4 4  502f115 1 5 f 4  8 9 8 f 4 7  2860h.1129 
RPMI 8402 TI 1' 1 6 f 4  4Y3f-16 290Yf553 13&4 4 2 0 f 5 0  9 7 9 f 1 8 2  
B lymphoblasts 
MGL 8 IgMK 1 8 f 6  2 7 f 7  2 9 f 3  1 2 & 3  1 6 f 4  1 8 f 2  
GM 558 IgMK 2 4 & 4  2 1 f 4  2 6 f 3  1 6 f 5  61*44 3 3 f l  
E.M. T l l t , T 4 +  3fl 8 f l  5 f l  2 f 2  8 f l  8 k 1  
O.B. T l l + , T 4 '  5 13 4 6 
L.K. T l l + .  T4+, T8+ 5 4 2 4 4 3 





5 f l  8 f 3  7 f l  4 f 2  6 f l  1 4 f 2  
Values represent the increment in deoxyATP or deoxyGTP pools over those in cells incubated in the 
presence of 10 ~ L M  2'-deoxycoformycin or 100 PM of 8-aminoguanosine respectively. Numbers 
represent the mean f SD of three determinations for cell lines and a single determination for patient 
cells. 
* Cells were incubated for 4 h or 24 h in the presence of 50 piv AdR and 10  p~ dCF. 
t Cells were incubated for 4 h or 24 h in the presence of 50 p~ GdR and 100 PM 8-AGuo. 
Purine metabolizing enzyme activities 
In order to determine whether any clear correlation exists between purine metabolizing 
enzyme activity and the relative lack of ability to accumulate deoxynucleoside triphosphates 
by either fresh or cultured CTCL cells, levels of cytoplasmic deoxycytidine, AdR, and 
adenosine phosphorylating activities as well as nucleotidase activity were measured. In 
addition, levels of ADA, PNP, ecto-5'-nucleotidase, and ecto-ATPase activities were 
determined (Tables IV and V). As had been reported previously (Blatt et al, 1982; Ma et al, 
1983). the CTCL cells have lower levels of ADA and higher levels of PNP activity than do the T 
lymphoblasts. Of particular interest, however, was the low level of ecto-5'-nucleotidase 
activity on CTCL cell lines, a characteristic not shared by the mature leukaemic T cells which 
were isolated directly from peripheral blood. The ability of cytoplasmic extracts to 
phosphorylate deoxycytidine and AdR tended to be lower in CTCL cell lines and patient cells 
than in T lymphoblasts, whereas adenosine kinase, cytoplasmic nucleotidase and ecto- 
ATPase activities were similar. 
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Table 111. Changes in ATP pools in lymphoid cell 
lines incubated with AdR and deoxycoformycin* 
Incubation time 
Cell lines 4 h  24  h 
CTCL 
HUT 78 + 2 4 f 1 2  -12*8 
HUT 102 S l l f 9  - 9 f 6  
T lymphoblasts 
MOLT 4 + 1 9 f 1 2  + 5 f 6  
RPMI 8402 - 1 6 f l l  -5Oh22 
B lymphoblasts 
MGL 8 - 3 6 f 1 4  f 1 3 1 t 7  
GM 558 - 4 1 f 3 0  S 3 0 f l l  
Changes in ATP pools are calculated as the 
percentage of those in control cells incubated 
with 10 p~ 2’-deoxycoformycin alone (mean 
f 1 SD of three experiments). Negative values 
reflect a decline in ATP pools. 
* Incubations were performed in the presence 
of 50 p~ AdR and 10 PM 2’-deoxycoformycin. 
Table IV. A comparison of purine metabolizing enzyme activities in lymphoid cells 
Deoxycytidine Deoxyadenosine Adenosine Adenosine Purine nucleoside 
kinase activity kinase activity* kinase activity* deaminaset phosphorylaset 
CTCL 
HUT 78 3.7 43.7 283.7 125.5 199.5 
HUT 102 3.9 37.0 202.4 130.8 109.3 
MOLT 4 8.6 82.2 130.2 690.0 74.4 
RPMI 8402 24.4 128.0 122.0 8 70.9 40.5 
MGL 8 6.0 23.3 156.0 18.0 76.1 




E.M. 13.8 67.4 261.4 129.5 263.9 
B.K. 5.7 42.1 125.1 12.9 332.6 
L.M. 7.11 46.4 61.2 56.9 297.0 
Enzyme activities were determined as outlined in methods and represent the mean of duplicate 
* nmol/h/mg protein: t nmol/min/mg protein. 
determinations for the cell lines and a single determination on the patients’ cells. 
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Table V. A comparison of nucleotidase activities in 
lymphoid cells 
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Ecto 5’- Cytoplasmic Ecto- 
nucleotidase* nucleotidaset ATPase* 
CTCL lines 
HUT 78 1.9 74.4 1.7 
HUT 102 0.5 86.7 < 1.0 
MOLT 4 0.1 22.7 <1*0 
RPMI 8402 0.1 52.3 < 1.0 
MGL 8 33.8 56.3 1260 




E.M. 32.1 N.D. N.D. 
B.K. 17.6 N.D. N.D. 
L.M. 2 5.6 N.D. N.D. 
* nmol/h/lOh cells; t nmol/h/mg protein: N.D., not 
done. 
DISCUSSION 
The mechanism of cytotoxicity to T lymphocytes in ADA and PNP deficiency diseases has 
received considerable attention because of the potential for selective pharmacologic 
manipulation of the immune system. It has become clear from the w x k  of several groups that 
deoxynucleoside triphosphate accumulation, which has been proposed to inhibit the enzyme 
ribonucleotide reductase and deplete the cells of other deoxynucleotides required for DNA 
synthesis, does not suffice to explain the toxic effects of AdR in particular for mature, 
non-dividing T lymphocytes (Kefford & Fox, 1982; Carson et al, 1982; Lee et al, 1984). 
Several alternative hypotheses for the toxicity of AdR, in the presence of an ADA inhibitor, for 
mature T cells have been offered. ATP depletion, observed to occur in erythrocytes of 
deoxycoformycin-treated patients (Siaw et al, 1980) and in T lymphoblasts exposed to very 
high AdR concentrations (Bagnara & Hershfield, 1982), has also been shown to occur in 
peripheral blood lymphocytes which accumulate dATP in vitro (Carson et al, 1982). There is 
also some evidence that the polyadenylation of mRNA is altered in the presence of dATP 
accumulation (Kefford et al, 19831, and that the overall rate of RNA synthesis in resting 
lymphocytes is decreased (Matsumoto et al, 1983). A third hypothesis to explain lymphocyte 
depletion involves the inhibition of S-adenosylhomocysteine hydrolase activity by AdR 
(Hershfield, 19 791, leading to the accumulation of S-adenosylhomocysteine and subsequent 
alterations in S-adenosylmethionine-mediated methylation reactions. 
Our study was designed to examine the metabolism of deoxynucleosides by lymphoid cells 
of mature phenotype. The use of lines obtained from patients with cutaneous T cell 
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leukaemias enabled us directly to compare the cytotoxic potential of AdR, GdR and TdR for 
these actively growing cells with that for immature T lymphoblasts. It is clear from these data 
that the preferential cytotoxicity of these deoxynucleosides for T, as compared to B, 
lymphoblasts does not extend to the mature T cell lines. In addition, the capability of these 
cells to accumulate dATP or dGTP from AdR or GdR, respectively, remains far less than that 
of the T lymphoblasts, suggesting that marked differences in purine metabolizing enzyme 
activities may occur during T cell maturation. 
Despite this supposition, measurements of cytoplasmic enzyme activities revealed only a 
slight reduction in deoxynucleoside phosphorylating activity in CTCL lines, using both AdR 
and deoxycytidine as substrates. The true significance of this observation is difficult to 
determine, given the limited number of cell lines of each type examined and the inability to 
clearly distinguish differences between T and B lymphoblasts on the basis of cytoplasmic 
kinase activities (Hershfield et al, 1982). In addition, cytoplasmic nucleotidase and 
ecto-ATPase activities were of little discriminating value. Thus, we cannot determine 
whether decreases in deoxynucleoside phosphorylating activity and/or increases in nucleoti- 
dase activity are responsible for the lesser ability of the mature T cells to accumulate 
deoxynucleotides. What has become clear, however, as that low ecto-5’-nucleotidase or 
ecto-ATPase activity does not directly correlate with the ability of cells to accumulate 
deoxynucleotides (Fox et al,  1981b: Carson et al. 1981: Mitchell & Edwards, 1984), a fact 
which is now further substantiated by the low activity of both enzymes in the CTCL lines we 
examined. 
Data on the clinical responsiveness of patients with mature T cell ncoplasms to 
2’-deoxycoformycin therapy are presently quite limited. However, since leukaemic cells of 
mature T cell phenotype are far more resistant to incubations with AdR and 2’-deoxycofor- 
mycin than are immature T lymphoblasts, one would have to postulate mechanisms of 
lymphocytotoxicity in these disorders which differ from those in T-cell acute lymphoblastic 
leukaemia. Since both the ATP depeletion theory and the abnormal polyadenylation theory 
depend on the accumulation of dATP, it is unlikely that either plays a leading role in killing 
mature T cells. Indeed, examination of the ATP pools in the incubated CTCL cells did not 
reveal a major degree of ATP depletion after 24 h, although the levels consistently dropped 
somewhat below baseline levels. Similarly, simple inhibition of S-adenosylhomocysteine 
hydrolase by AdR would also be expected to occur in the in vitro setting and hence would not 
explain the lack of susceptibility of CTCL cells to AdR toxicity. It is certainly possible that 
inhibition of ADA activity in vivo leads to metabolic consequences which cannot be predicted 
by simple in vitro incubation systems. Alternately, more extensive clinical data may not 
support a truly selective toxicity of adenosine deaminase inhibition for mature, malignant T 
cells. 
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